177Lu-Dotatate for Midgut Neuroendocrine Tumors

被引：0
|
作者：
Matuchansky, Claude [1 ]
机构：
[1] Paris Diderot Univ, Paris, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1391 / 1391
页数：1
相关论文
共 50 条
  • [1] 177Lu-Dotatate for midgut neuroendocrine tumours
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2017, 18 (02): : E74 - E74
  • [2] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Strosberg, J.
    El-Haddad, G.
    Wolin, E.
    Hendifar, A.
    Yao, J.
    Chasen, B.
    Mittra, E.
    Kunz, P. L.
    Kulke, M. H.
    Jacene, H.
    Bushnell, D.
    O'Dorisio, T. M.
    Baum, R. P.
    Kulkarni, H. R.
    Caplin, M.
    Lebtahi, R.
    Hobday, T.
    Delpassand, E.
    Van Cutsem, E.
    Benson, A.
    Srirajaskanthan, R.
    Pavel, M.
    Mora, J.
    Berlin, J.
    Grande, E.
    Reed, N.
    Seregni, E.
    Oberg, K.
    Sierra, M. Lopera
    Santoro, P.
    Thevenet, T.
    Erion, J. L.
    Ruszniewski, P.
    Kwekkeboom, D.
    Krenning, E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 125 - 135
  • [3] Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Srirajaskanthan, Rajaventhan
    El-Haddad, Ghassan
    Wolin, Edward M.
    Chasen, Beth R.
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hendifar, Andrew E.
    Oberg, Kjell
    Ruszniewski, Philippe
    Santoro, Paola
    Broberg, Per
    Leeuwenkamp, Oscar R.
    Krenning, Eric P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12): : 1712 - 1718
  • [4] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [5] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [6] Dosimetric studies of 177Lu-DOTATATE administered into neuroendocrine tumors
    Gupta, Santosh
    Singla, Suhas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Bal, C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [7] COST-EFFECTIVENESS ANALYSIS OF RE-TREATMENT WITH 177LU-DOTATATE VERSUS NO RE-TREATMENT WITH 177LU-DOTATATE IN PATIENTS WITH PROGRESSIVE MIDGUT NEUROENDOCRINE TUMORS
    Leeuwenkamp, O.
    Mahon, R.
    Singh, M. K.
    Khare, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S446 - S446
  • [8] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [9] 177Lu-DOTATATE Treatment In Unresectable Neuroendocrine Tumors: Our Experience
    Agudelo, M.
    Bello-Arques, P.
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Martinez-Sanchis, B.
    Bernal-Vergara, J.
    Figueroa-Ardila, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S596 - S597
  • [10] Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors
    Assi, Hussein A.
    Hornbacker, Kathleen
    Shaheen, Shagufta
    Wittenberg, Theresa
    Silberman, Robyn
    Kunz, Pamela L.
    [J]. PANCREAS, 2021, 50 (06) : 890 - 894
12345